BETTER THERAPEUTICS (BTTX) Stock Price, News & Analysis
Company Description
BETTER THERAPEUTICS (OTC Link: BTTX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $5.5K.
BTTX has gained 0.0% over the past year. Shares last traded at $0.0001.
For FY2022, BETTER THERAPEUTICS reported net income of -$39.8M and diluted earnings per share of $-1.69.
This page collects what Stock Titan holds for BTTX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BETTER THERAPEUTICS (BTTX) stock last closed at $0.0001. Over the past 12 months, the stock has gained 0.0%. At a market capitalization of $5.5K, BTTX is classified as a micro-cap stock with approximately 54.5M shares outstanding.
Latest News
BETTER THERAPEUTICS has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include partnership, fda approval. View all BTTX news →
SEC Filings
Financial Highlights
operating income reached -$38.3M, and net income was -$39.8M. Diluted earnings per share stood at $-1.69. The company generated -$28.9M in operating cash flow. With a current ratio of 1.37, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Short interest in BETTER THERAPEUTICS (BTTX) currently stands at 1.0 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for BETTER THERAPEUTICS (BTTX) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 23.0 days.
BTTX Company Profile & Sector Positioning
BETTER THERAPEUTICS (BTTX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BTTX often look at related companies in the same sector, including Novaccess Global Inc (XSNX), Statera Biopharma Inc (STAB), Renovacare (RCAR), Comera Life (CMRA), and Ampio Pharma (AMPE). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BTTX's relative position within its industry.